3SBio Inc.

3SBio Inc. Announces Results of Annual General Meeting.
Biotech Week; 11/4/2009; 559 words; 3SBio Inc. (NASDAQ:SSRX) ("3SBio" or "Company...shareholders held on October 12, 2009 (see also 3SBio Inc.). At the meeting, the Company's shareholders...year ending December 31, 2009. Keywords: 3SBio Inc., Biopharmaceuticals, Drugs, Therapies...

Orexigen Prices IPO To Raise $84M For Obesity Programs.
BIOWORLD Today; 11/3/2009; 1190 words; ...far this year, Orexigen Therapeutics Inc. priced 7 million shares at $12 apiece...That puts it behind Chinese firm 3SBio Inc.'s $115.2 million offering in...based Molecular Insight Pharmaceuticals Inc. (See BioWorld Today, Feb. 21...

News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ:TOMO).
M2 Presswire; 10/28/2009; 847 words; ...BiomedReports: News and FDA Updates for 3SBio (Nasdaq:SSRX), TomoTherapy (NASDAQ...BioMedReports.Com On 10/27/09, 3SBio Inc. (Nasdaq:SSRX), a leading China...2009. On 10/27/09, TomoTherapy Inc., (NASDAQ:TOMO) announced four...

3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009.
PR Newswire; 10/27/2009; 641 words; ...China, Oct. 27 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio" or "the Company"), a leading China-based biotechnology...within one hour after the conclusion of the call. About 3SBio Inc. 3SBio Inc. is a leading, fully integrated biotechnology...

ChinaBio[R] Day Unveils Program Highlights.
Biotech Week; 9/23/2009; 1076 words; ...External Research, Merck & Co., Inc.; and Steve Yang, PhD, VP and Head...Research; Yingfei Wei, PhD, CSO, 3SBio, Inc.; Frank Torti, MD, Senior Associate...Business Development, BioDuro, Inc.; and Yu Zhao, PhD, VP, Tianjin...